A library of novel trans-ethyl 5-aroyl-4-aryl-2-[(arylsulfonyl)methyl]-4,5-dihydrofuran-3-carboxylates were synthesized regio-and stereoselectively in good yields by a three-component domino reaction of ethyl-3-oxo-4-(arylsulfonyl)butanoates, aromatic aldehydes and Nphenacylpyridinium bromide in presence of triethylamine in acetonitrile under heating. This transformation generates C-O, C-C and C=C bonds and presumably proceeds via an α,β-unsaturated ketosulfonyl ester generation/Michael addition/intramolecular cyclisation domino sequence.
Introduction
Multicomponent reactions (MCRs) have emerged as an important synthetic strategy for generating complex scaffolds of structural diversity from simple molecules. In this protocol, three or more reactants are assembled together in a one pot operation to form a new product comprising substantial portions of all the components. [1] [2] [3] MCRs, besides generating complex structures, provide operational simplicity and synthetic efficiency over conventional linear multistep reactions. The most useful MCRs have additional advantages of selectivity, synthetic convergence, atom-economy and green credentials. [4] [5] [6] [7] [8] [9] Further, MCRs are perfectly amenable for automation to generate combinatorial libraries of biologically relevant heterocyclic scaffolds and hence play a pivotal role in lead identification and drug development programmes.
Furan and di-/tetrahydrofuran sub-structures are prevalent in diverse classes of natural products and biologically active heterocycles, besides serving as versatile building blocks in organic synthesis [10] [11] [12] and several synthetically derived sulfones also show interesting biological activities ( Figure 1 ). For instance, dapsone 1 is an important drug currently used for the treatment of leprosy in conjunction with other drugs. 13 1-(4-Trifluoromethyl)-phenyl-2-(phenylsulfonyl)ethanone 2 inhibits of 11β-hydroxysteroid dehydrogenase activity, 14 whilst
substituted (E)-(2-chloro-2-(phenylsulfonyl)vinyl)benzenes 3 show antiplasmodial activity. 15 Sulfones appended to furan moiety also show important biological activities. For example, functionalized vinyl dihydrofuryl sulfones 4 and tetrahydrofuryl sulfones 5 show antiprotozoal 16 and antimycobacterial activity 17 respectively. Consequently, in the present work, we report the regio-and stereoselective synthesis of highly functionalized biologically relevant dihydrofurans bearing arylsulfonyl moiety 6. Previously reported synthesis of dihydrofuran derivatives include the reactions of sulfur ylide with α-ylidene-β-diketones via [4+1] annulation reaction, 18, 19 one-step cyclization of β-ketosulfides of benzothiazole and aldehydes in ionic liquids, 20 reaction of β-ketopolyfluoroalkane sulfones with aldehydes, 21 reactions of 1,3-dicarbonyl compounds with appropriate olefins, [22] [23] [24] or α-bromonitroalkenes. 25 Cyclization as well as ring enlargement reaction are mostly used for the construction of dihydrofurans. [26] [27] [28] [29] The reaction of pyridinium ylides with α,β-unsaturated carbonyl systems, [30] [31] [32] [33] is one of the most familiar and frequently used synthetic methods for the construction of dihydrofurans, the ylides, in turn, can be easily prepared by deprotonation of the α-halogenocarbonyl compounds. Present study constitutes a part of our ongoing research program launched on the exploration of tandem/domino/sequential multi-component reactions for the assembly of novel heterocycles.
Results and Discussion
In the present investigation, a library of novel trans-ethyl 5-aroyl-4-aryl-2-[(arylsulfonyl)methyl]-4,5-dihydrofuran-3-carboxylates 10 were synthesized regio-and stereoselectively in good yields by a three-component domino reaction of ethyl-3-oxo-4-(arylsulfonyl)butanoates 7, aromatic aldehydes 8 and N-phenacylpyridinium bromide 9 in the presence of triethylamine in acetonitrile under heating. The base-and sovent-screen for the model reaction leading to 10k was studied and the results are presented in Table 1 CH 3 CN. After the completion of the reaction (TLC), the solvent was removed in a rotary evaporator and the residue was purified by column chromatography using ethyl acetate-pet.ether The H-5 shows a C,H-COSY correlation with the carbon signal at 89.5 ppm and shows HMBCs with C-4, C-3, C-1' and C-2 at 50.2, 112.4, 139.8 and 156.9 ppm respectively. The diastereotopic methylene hydrogens attached to the sulfonyl group give a doublet at 4.95 ppm (J 13.8 Hz) and a doublet of doublets at 4.63 ppm (J 13.8, 1.5 Hz) and these hydrogens show C,H-COSY correlations with the carbon signal at 54.7 ppm and HMBCs with C-2 and C-3 carbons. Ester methylene hydrogens appeared as a multiplet in the region of 3.86-3.94 ppm and methyl hydrogens appeared as a triplet at 1.00 ppm (J 7.2 Hz). The structure of 10n deduced from NMR spectroscopic data is in good accord with that determined from the X-ray crystallographic studies on a single crystal of 10n 39 (Figure 4 ).
This transformation leading to the formation of dihydrofurans (Scheme 2) is presumably triggered by an initial regioselective condensation of ketosulfonyl ester 7 with aromatic aldehyde 8 affording 11. This regioselectivity might probably arise from the steric hindrance posed by the bulky arylsulfonyl moiety to the condensation of the aromatic aldehyde with the methylene flanked by the sulfonyl and keto groups, which is likely to impede the formation of 11'. Subsequent Michael addition of the pyridinium ylide 12 to the acceptor 11 furnishes the enolate 13, which undergoes intramolecular cyclisation by the displacement of pyridine to afford exclusively the regioisomer 10. Ethyl5-benzoyl-4-phenyl-2-((p-methylphenylsulfonyl)methyl)-4,5-dihydrofuran-3-carboxylate (10a) trans-Ethyl5-benzoyl-4-(2-bromophenyl)-2-((p-methylphenylsulfonyl)methyl)-4,5-dihydrofuran-3-carboxylate (10f) -benzoyl-2-((4-chlorophenylsulfonyl)methyl)-4-(4-methylphenyl) -benzoyl-2-((4-chlorophenylsulfonyl)methyl)-4-(3-fluorophenyl)-4,5-dihydrofuran-3-carboxylate (10o) 
trans-Ethyl5-benzoyl-4-(4-nitrophenyl)-2-((p-methylphenylsulfonyl)methyl)-4,5-dihydrofuran-3-carboxylate (10d

